Transition in Healthcare Focus Undergoes Formal Corporate Update
Following the recent approval and statutory registration, S.G. Power Limited (PSX) has officially transitioned its business focus within the pharmaceutical sector. The company completed necessary regulatory steps after passing a Special Resolution during its Extraordinary General Meeting on May 13, 2026, and registered its amended Memorandum of Association. This shift enables PSX to manage medical equipment, devices, hospital supplies, and a wide range of pharmaceutical and allied products. The company is also actively preparing the necessary name change process to better reflect its updated business priorities. This development marks a significant milestone in its strategic growth within Pakistan’s healthcare landscape.
The company aims to solidify its regulatory compliance while expanding its role in the pharmaceutical industry. Detailed communications about this transition were issued to the Pakistan Stock Exchange and all relevant stakeholders.